Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. G.A. Huls

Publicaties

Author Correction: Whole-body CD8 + T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients

Impact of Rituximab Maintenance on Survival in Patients with Mantle Cell Lymphoma; a Population-based Cohort Study

Metformin induces ferroptosis associated with lipidomic remodeling in AML

Multi-omic profiling and preclinical efficacy of fratricide-driven, unedited CD7 CAR-T cells in T-cell leukemia

Selective Targeting of Immune Checkpoints HLA-G and CD47 Using Novel Dual Signaling Protein DSP216 Promotes Innate Anticancer Immunity

ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia

A revised prognostic model for patients with acute myeloid leukemia and first relapse

Beneficial effect of PTCy and a short duration of immune suppression on relapse risk in acute myeloid leukemia patients with pretransplant MRD

Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia

Pers/media

Professor Dr. Gerwin Huls te gast bij Nutsdepartement Vlagtwedde

Professor Dr. Gerwin Huls te gast bij Nutsdepartement Vlagtwedde

Nationaal Groeifonds investeert in UMCG-studies om ontwikkeling kankermedicijnen te versnellen